Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
GI-13020, GS-4774
print preview
bookmark
share with colleague
General Information
Company
GlobeImmune Inc.
Description
Whole heat-killed recombinant Saccharomyces cerevisiae genetically engineered (Tarmogen) to express HBV antigens
Molecular Target
HBV antigens
Mechanism of Action
Vaccine
Latest Stage of Development
Phase I
Indication
Hepatitis B virus (HBV)
Partner
Gilead Sciences Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy